Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of intranasal lidocaine on pain score in
pediatric patients with migraine. Patients with significant pain after oral analgesics and
plan for intravenous (IV) abortive therapy will be asked to participate. Half of patients
will be given intranasal lidocaine and the other half will be given placebo. Pain scores and
associated migraine symptoms (i.e. nausea, vomiting, photophobia, phonophobia, avoidance of
activities, and aura) will be monitored and compared between the groups.